Elpen Pharmaceutical Co. Inc
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
ELPEN is a distinguished Greek pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products through direct operations (B2C) and strategic partnerships (B2B). Over six decades, it has expanded its footprint across global markets, exporting to more than 90 countries and employing over 1,500 professionals. With a dominant presence in Greece—ranking #1 in sales—the company has established subsidiaries in Germany and the UAE. ELPEN demonstrates a strong commitment to Research & Development, allocating over 15% of its annual revenue to advancements in Respiratory, Intranasal Deliveries, Fixed-Dose Combinations, and High-Potent products. Its four manufacturing sites, all located in Greece, operate under rigorous international standards, including EUGMP and ISO certifications, ensuring high-quality production and regulatory compliance.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}